Komori
Changes in Officers4512WAKAMOTO PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice Regarding the Election of a Candidate for Outside Director

樋川加奈 (Higawa Kana) has newly been selected as a candidate for outside director, and the appointment will be submitted to the Annual General Meeting of Shareholders. If approved, the number of outside directors will increase by 1 to 3 of the 10 directors.

Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
1
Directors (increase in outside directors)
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 2024年3月22日

Incoming appointee

1 item
Scheduled Appointment Date2024年6月下旬開催予定の第129回定時株主総会の承認を条件に正式決定
樋川 加奈
New positionCandidate for outside director serving as an Audit & Supervisory Committee Member
生年月日 1976年2月18日
Directors after the change10Numberof which 3 outside
Filing as an independent officer選任が承認された場合は、独立役員として東京証券取引所に届け出る予定
Shareholders’ meeting approval要する。議案名:樋川加奈氏の社外取締役選任議案(監査等委員である社外取締役候補者の選任)。開催予定日:2024年6月下旬開催予定の第129回定時株主総会This appointment will not be formally finalized until it is approved at the general meeting of shareholders.
Reason for change

経営の透明性をさらに向上させ、コーポレート・ガバナンス体制の一層の強化を図ることを目的として1名増員し、候補者を選任

Reasons for appointment

公認会計士として企業の会計監査に従事し、特に企業会計に関する高度な知識と経験を有しているため。同氏の知見、経験に基づき、当社の事業活動の公平、公正な決定及び経営の健全性確保に対する助言・提言が期待されるため

“Outside” refers to directors who oversee management without having come from the company.Independent officers are outside officers registered with the exchange as having no conflict of interest with general shareholders.
Who is moving to which position
ItemDetails
Resolution date2024年3月22日
Scheduled Appointment Date2024年6月下旬開催予定の第129回定時株主総会の承認を条件に正式決定
Name of appointee樋川 加奈
Appointee's new positionCandidate for outside director serving as an Audit & Supervisory Committee Member
Appointee's date of birth1976年2月18日
Reason for change経営の透明性をさらに向上させ、コーポレート・ガバナンス体制の一層の強化を図ることを目的として1名増員し、候補者を選任
Reasons for appointment公認会計士として企業の会計監査に従事し、特に企業会計に関する高度な知識と経験を有しているため。同氏の知見、経験に基づき、当社の事業活動の公平、公正な決定及び経営の健全性確保に対する助言・提言が期待されるため
Number of directors after the change10名中3名が社外取締役となる予定
Filing as an independent officer選任が承認された場合は、独立役員として東京証券取引所に届け出る予定
Subject to Approval by the General Meeting of Shareholders要する。議案名:樋川加奈氏の社外取締役選任議案(監査等委員である社外取締役候補者の選任)。開催予定日:2024年6月下旬開催予定の第129回定時株主総会
Items this document does not state (11)
Date of departureAppointee's previous positionYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

経営の透明性をさらに向上させ、コーポレート・ガバナンス体制の一層の強化を図るため。また、樋川氏の企業会計に関する高度な知識と経験に基づく助言・提言が期待されるため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Election of a Candidate for Outside Director | WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) timely disclosure | Komori